Role of immunocompetent cells in nonimmune renal diseases

Slides:



Advertisements
Similar presentations
Volume 62, Pages S12-S22 (December 2002)
Advertisements

Volume 59, Issue 6, Pages (June 2001)
Volume 63, Issue 1, Pages (January 2003)
M.S. Mozaffari, C. Patel, R. Abdelsayed, S.W. Schaffer 
Volume 58, Issue 4, Pages (October 2000)
Volume 82, Issue 1, Pages 7-8 (July 2012)
Volume 53, Issue 4, Pages (April 1998)
Volume 64, Pages S27-S32 (October 2003)
Volume 61, Issue 4, Pages (April 2002)
Membranous nephropathy: When and how to treat
Volume 64, Issue 1, Pages (July 2003)
Volume 68, Issue 5, Pages (November 2005)
Volume 55, Issue 5, Pages (May 1999)
Volume 23, Issue 2, Pages (February 2016)
Volume 66, Issue 5, Pages (November 2004)
Volume 60, Issue 3, Pages (September 2001)
Volume 63, Issue 4, Pages (April 2003)
Volume 68, Issue 3, Pages (September 2005)
The intrarenal renin-angiotensin system in hypertension
Volume 54, Issue 6, Pages (January 1998)
Volume 59, Issue 5, Pages (May 2001)
Volume 55, Issue 4, Pages (April 1999)
Volume 81, Issue 9, Pages (May 2012)
Volume 58, Issue 1, Pages (July 2000)
Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension  Tyrus Stewart, Flavia F. Jung, Jennifer Manning,
Volume 54, Issue 5, Pages (November 1998)
Volume 63, Issue 5, Pages (May 2003)
Volume 74, Pages S55-S59 (December 2008)
Volume 64, Pages S46-S51 (October 2003)
Volume 86, Issue 4, Pages (October 2014)
Volume 70, Issue 7, Pages (October 2006)
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis
Volume 58, Issue 3, Pages (September 2000)
Volume 63, Issue 2, Pages (February 2003)
Volume 67, Issue 1, Pages (January 2005)
Volume 62, Issue 2, Pages (August 2002)
Volume 63, Issue 6, Pages (June 2003)
Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes  Choong H. Kim, Nosratola D. Vaziri  Kidney.
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?  Mustafa Arici, John Walls  Kidney International 
Volume 75, Issue 2, Pages (January 2009)
Saulo Klahr, Jeremiah J. Morrissey  Kidney International 
Volume 64, Issue 3, Pages (September 2003)
Volume 64, Issue 1, Pages (July 2003)
Volume 67, Issue 2, Pages (February 2005)
Volume 23, Issue 2, Pages (February 2016)
Volume 66, Issue 4, Pages (October 2004)
Volume 71, Issue 9, Pages (May 2007)
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis  H.-C. Yang, L.-J. Ma, J. Ma, A.B. Fogo 
Volume 61, Issue 3, Pages (March 2002)
Volume 59, Issue 5, Pages (May 2001)
Volume 63, Issue 3, Pages (March 2003)
CD4+ T cells: a potential player in renal fibrosis
Tubulointerstitial damage and progression of renal failure
Volume 62, Issue 4, Pages (October 2002)
Angiotensin II: breathtaking in the renal medulla
Volume 57, Issue 1, Pages (January 2000)
Endothelial cell activation
Volume 62, Issue 4, Pages (October 2002)
Volume 58, Issue 4, Pages (October 2000)
End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link?  Mustafa Arici, John Walls  Kidney International 
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Volume 56, Issue 6, Pages (December 1999)
Volume 68, Issue 5, Pages (November 2005)
Is it the low-protein diet or simply the salt restriction?
Volume 74, Issue 9, Pages (November 2008)
Effect of prenatal dexamethasone on rat renal development
T cells and T-cell receptors in acute renal failure
Plasmin is not protective in experimental renal interstitial fibrosis1
Eric N Haugen, Anthony J Croatt, Karl A. Nath  Kidney International 
Volume 75, Issue 2, Pages (January 2009)
Presentation transcript:

Role of immunocompetent cells in nonimmune renal diseases Bernardo Rodríguez-Iturbe, Héctor Pons, Jaime Herrera-Acosta, Richard J. Johnson  Kidney International  Volume 59, Issue 5, Pages 1626-1640 (May 2001) DOI: 10.1046/j.1523-1755.2001.0590051626.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Interrelation between nonimmune conditions associated with accumulation and activation of immunocompetent cells in the kidney. The influx and activation of cells of the immune system results from a complex interrelation of factors that stimulate the production of chemoattractants and adhesion molecules. Proteinuria, oxidized lipoproteins, obstruction to urine flow, and ischemia are conditions that stimulate the renin-angiotensin system and the production of reactive oxygen species (ROS), both of which induce the production of chemotactic factors and expression of adhesion molecules (discussed in this article). Macrophages and lymphocytes not only have angiotensin II subtype 1A (AT1A) receptors[147], but are also capable of generating ROS[129],[149] and angiotensin II in response to angiotensinogen or angiotensin I peptides[215],[216], thus having the potential for retrograde stimulation of the cycle. Chronic hypoxia[127] and angiotensin II (Ang II)[217] are capable of inducing a variety of growth factors and fibrosis. Kidney International 2001 59, 1626-1640DOI: (10.1046/j.1523-1755.2001.0590051626.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Relationship of interstitial macrophage infiltration to systolic blood pressure in catecholamine-induced hypertension[94]. In this study, rats were administered phenylephrine for eight weeks. During this time, blood pressure was episodically elevated. At the end of the infusion one kidney was removed and the number of ED-1-positive macrophages in the interstitium was determined (semiquantitative score 0 to 5). Rats were subsequently placed on a high (8% NaCl) salt diet for four to eight weeks. Shown is the systolic blood pressure at the end of the study. (, vehicle-perfused rats; , phenylephrine-infused rats; N = 17, r2 = 0.48, P < 0.003). Kidney International 2001 59, 1626-1640DOI: (10.1046/j.1523-1755.2001.0590051626.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Lymphocyte infiltration in the renal ablation model. Photomicrographs demonstrating lymphocyte infiltration [staining with fluorescein-labeled monoclonal antibody (mAb) anti-CD5] in the remnant kidney four weeks after 5/6 nephrectomy in the rat. In this model, proteinuria was prevented and renal function and structure were markedly preserved by mycophenolate mofetil (MMF) treatment, which reduced infiltration of lymphocytes and macrophages and expression of adhesion molecules[54]. Kidney International 2001 59, 1626-1640DOI: (10.1046/j.1523-1755.2001.0590051626.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 Effects of mycophenolate mofetil (MMF) on the infiltration of lymphocytes in atherosclerosis. (A) Lymphocyte infiltration in the aorta of a rabbit fed with a high (1%) cholesterol diet for 12 weeks (staining with peroxidase-labeled mAb anti-CD5). (B) Treatment with MMF (30mg daily by gastric gavage) is associated with marked reduction in lymphocyte infiltration. Similar reductions were found in macrophage infiltration, cholesterol content of the aorta and atherosclerotic plaques[188]. Kidney International 2001 59, 1626-1640DOI: (10.1046/j.1523-1755.2001.0590051626.x) Copyright © 2001 International Society of Nephrology Terms and Conditions